Susceptibility profile of Candida rugosa (Diutina rugosa) against antifungals and compounds of essential oils

A Ludwig,F P K de Jesus,V Dutra,S L Cândido,S H Alves,J M Santurio
DOI: https://doi.org/10.1016/j.mycmed.2019.03.002
Abstract:Candida rugosa (recently reclassified Diutina rugosa) is an emerging pathogen affecting humans and animals. Candida resistance to existing drugs is an important factor to be monitored, as well as the need of researching alternatives to conventional antifungals. Here, we evaluated the in vitro effects of some antifungals and major components of essential oils by the broth microdilution method (CLSI M27-A3) against fifteen C. rugosa strains from animals isolated and molecular identificated. The results showed MIC90 of: 0.125μg/mL to ketoconazole and voriconazole, 0.25μg/mL to micafungin, 0.5μg/mL to anidulafungin, 1μg/mL to caspofungin, 2μg/mL to amphotericin B, itraconazole and flucytosin, 8μg/mL to fluconazole, 16μg/mL to nystatin and >128μg/mL to terbinafine. The compounds carvacrol (MIC90 320μg/mL), thimol (MIC90 320μg/mL) and cinnamaldehyde (MIC90 160μg/mL) demonstrated antifungal activity against the samples tested.
What problem does this paper attempt to address?